Efficacy of ferulic acid encapsulated chitosan nanoparticles against Candida albicans biofilm

Microbial Pathogenesis

Volumn 95, Issue , 2016, Pages 21-31

  Panwar, Richa ^a   Pemmaraju, Suma C ^a   Sharma, Asvene K ^a   Pruthi, Vikas ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY ROORKEE   (India)

Author keywords

Antibiofilm activity; Chitosan nanoparticles; Cytocompatibility; Ferulic acid; FESEM

Indexed keywords

CHITOSAN NANOPARTICLE; FERULIC ACID; 1,5-BIS(2-METHOXY-4-NITRO-5-SULFOPHENYL)-3-((PHENYLAMINO)CARBONYL)FORMAZAN; ANTIFUNGAL AGENT; BIOMATERIAL; CHITOSAN; COUMARIC ACID; DRUG CARRIER; FORMAZAN; NANOPARTICLE;

ARTICLE; BIOFILM; CANDIDA ALBICANS; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG EFFICACY; ENCAPSULATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; FLUORESCENCE MICROSCOPY; GELATION; HEK293 CELL LINE; HUMAN; HUMAN CELL; INFRARED SPECTROSCOPY; IONOTROPIC GELATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THERMOGRAVIMETRY; XTT ASSAY; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; EPITHELIUM CELL; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; STAINING; ULTRASTRUCTURE;

ANTIFUNGAL AGENTS; BIOCOMPATIBLE MATERIALS; BIOFILMS; CANDIDA ALBICANS; CELL LINE; CELL SURVIVAL; CHITOSAN; COUMARIC ACIDS; DRUG CARRIERS; EPITHELIAL CELLS; FORMAZANS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAINING AND LABELING;

EID: 84960917118     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2016.02.007     Document Type: Article

References (41)

1. Kojic E.M., Darouiche R.O. Candida infections of medical devices. Clin. Microbiol. Rev. 2004, 17:255-267.
2. Lane R.K., Matthay M.A. Central line infections. Curr. Opin. Crit. Care 2002, 8:441-448.
3. Ortega M., Marco F., Soriano A., Almela M., Martínez J.A., López J., Pitart C., Mensa J. Candida species bloodstream infection: epidemiology and outcome in a single institution from 1991 to 2008. J. Hosp. Infect. 2011, 77:157-161.
4. Crump J.A., Collignon P.J. Intravascular catheter-associated infections. Eur. J. Clin. Microbiol. Infect. Dis. 2000, 19:1-8.
5. Ramage G., Wickes B.L., López J. Biofilms of Candida albicans and their associated resistance to antifungal agents. Am. Clin. Lab. 2001, 20:42-44.
6. Zhang A.Y., Camp W.L., Elewski B.E. Advances in topical systemic antifungals. Dermatol. Clin. 2007, 25:165-183.
7. Pauli A. Anticandidal low molecular compounds from higher plants with special reference to compounds from essential oils. Med. Res. Rev. 2006, 26:223-268.
8. Alavarce R.A.S., Saldanha L.L., Almeida N.L.M., Porto V.C., Dokkedal A.L., Lara V.S. The beneficial effect of equisetum giganteum L. against Candida biofilm formation: new approaches to denture stomatitis. J. Evid. Based Complement. Altern. Med. 2015, 1-9.
9. Raut J.S., Shinde R.B., Chauhan N.M., Karuppayil S.M. Phenylpropanoids of plant origin as inhibitors of biofilm formation by Candida albicans. J. Microbiol. Biotechnol. 2014, 24:1216-1225.
10. Ramage G., Saville S.P., Thomas D.P., Ribot J.L.L. Candida biofilms: an update. Eukaryot. Cell. 2005, 4:633-638.
11. Munin A., Lévy F.E. Encapsulation of natural polyphenolic compounds; a review. Pharmaceutics 2011, 3:793-829.
12. Wimardani Y.S., Suniarti D.F., Freisleben H.J., Wanandi S.I., Ikeda M.A. Cytotoxic effects of chitosan against oral cancer cell lines is molecular weight-dependent and cell-type-specific. Int. J. Oral Res. 2012, 3:1-10.
13. Patrulea V., Ostafe V., Borchard G., Jordan O. Chitosan as a starting material for wound healing applications. Eur. J. Pharm. Biopharm. 2015, 97:417-426.
14. Ing L.Y., Zin N.M., Sarwar A., Katas H. Antifungal activity of chitosan nanoparticles and correlation with their physical properties. Int. J. Biomater. 2012, 1-9.
15. Dhillon G.S., Kaur S., Brar S.K. Facile fabrication and characterization of chitosan-based zinc oxide nanoparticles and evaluation of their antimicrobial and antibiofilm activity. Int. Nano Lett. 2014, 4:107-118.
16. Keawchaoon L., Yoksan R. Preparation, characterization and in vitro release study of carvacrol-loaded chitosan nanoparticles. Colloids Surf. B Biointerfaces 2011, 84:163-171.
17. Vashisth P., Sharma M., Kumar N., Singh H., Panwar R., Pruthi P.A., Pruthi V. Antiproliferative activity of ferulic acid-encapsulated electrospun PLGA/PEO nanofibers against MCF-7 human breast carcinoma cells. 3Biotech 2015, 5:303-315.
18. Singh N., Pemmaraju S.C., Pruthi P.A., Cameotra S.S., Pruthi V. Candida biofilm disrupting ability of di-rhamnolipid (rl-2) produced from Pseudomonas aeruginosa DSVP20. Appl. Biochem. Biotechnol. 2013, 169:2374-2391.
19. Roehm N., Rogers G., Hatfield S., Glasebrook A. An improved colorimetric assay for cell proliferation and viability utilizing the tetrazolium salt XTT. J. Immunol. Methods 1991, 142:257-265.
20. Lee J.S., Kim G.H., Lee H.G. Characteristics and antioxidant activity of Elsholtzia splendens extract-loaded nanoparticles. J. Agric. Food Chem. 2010, 58:3316-3321.
21. Müller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47:3-19.
22. Woranuch S., Yoksan R. Eugenol-loaded chitosan nanoparticles: I. Thermal stability improvement of eugenol through encapsulation. Carbohydr. Polym. 2013, 96:495-502.
23. Sindhu M., Abraham T.E. Characterisation of ferulic acid incorporated starch-chitosan blend films. Food Hydrocoll. 2008, 22:826-835.
24. Rossi C., Schoubben A., Ricci M., Perioli L., Ambrogi V., Latterini L., Aloisi G.G., Rossi A. Intercalation of the radical scavenger ferulic acid in hydrotalcite-like anionic clays. Int. J. Pharm. 2005, 295:47-55.
25. Sohn Y.T., Oh J.H. Characterization of physicochemical properties of ferulic acid. Arch. Pharm. Res. 2003, 26:1002-1008.
26. Liu J., Wen X., Lu J., Kan J., Jin C. Free radical mediated grafting of chitosan with caffeic and ferulic acids: structures and antioxidant activity. Int. J. Biol. Macromol. 2014, 65:97-106.
27. Galati G., O'Brien P.J. Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties. Free Radic. Biol. Med. 2004, 37:287-303.
28. Heim K.E., Tagliaferro A.R., Bobilya D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem. 2002, 13:572-584.
29. Qi L., Xu Z., Jiang X., Hu C., Zou X. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr. Res. 2004, 339:2693-2700.
30. Maurya D.K., Devasagayam T.P.A. Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acids. Food Chem. Toxicol. 2010, 48:3369-3373.
31. Park J.H., Saravanakumar G., Kim K., Kwon I.C. Targeted delivery of low molecular drugs using chitosan and its derivatives. Adv. Drug Deliv. Rev. 2010, 62:28-41.
32. Panwar R., Sharma A.K., Kaloti M., Dutt D., Pruthi V. Characterization and anticancer potential of ferulic acid-loaded chitosan nanoparticles against ME-180 human cervical cancer cell lines. Appl. Nanosci. 2015, 10.1007/s13204-015-0502-y.
33. Garćia-Rincon J., Vega-Ṕerez J., Guerra-Śanchez M.G., Hernandez-Lauzardo A.Ń., Péna-Díaz A., Velazquez-DeĺValle M.G. Effect of chitosan on growth and plasma membrane properties of Rhizopusstolonifer (Ehrenb.:Fr.) Vuill. Pest Biochem. Physiol. 2010, 97:275-278.
34. Liu H., Du Y., Wang X., Sun L. Chitosan kills bacteria through cell membrane damage. Int. J. Food Microbiol. 2004, 95:147-155.
35. Tan H., Ma R., Lin C., Liu Z., Tang T. Quaternized chitosan as an antimicrobial agent: antimicrobial activity, mechanism of action and biomedical applications in orthopedics. Int. J. Mol. Sci. 2013, 14:1854-1869.
36. Roller S., Covill N. The antifungal properties of chitosan in laboratory media and apple juice. Int. J. Food Microbiol. 1999, 47:67-77.
37. Singh T., Vesentini D., Singh A.P., Daniel G. Effect of chitosan on physiological, morphological, and ultrastructural characteristics of wood-degrading fungi. Int. Biodeterior. Biodegr. 2008, 62:116-124.
38. Hemaiswarya S., Doble M.J. Synergistic interaction of phenylpropanoids with antibiotics against bacteria. Med. Microbiol. 2010, 59:1469-1476.
39. Pemmaraju S.C., Pruthi P.A., Prasad R., Pruthi V. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole. Ind. J. Exp. Biol. 2013, 51:1032-1037.
40. Kumar P., Mishra S., Malik A., Satya S. Preparation and characterization of PEG-mentha oil nanoparticles for housefly control. Colloids Surf. B Biointerfaces 2014, 116:707-713.
41. Lee D.S., Woo J.Y., Ahn C.B., Je J.Y. Chitosan hydroxycinnamic acid conjugates: preparation, antioxidant and antimicrobial activity. Food Chem. 2014, 148:97-104.